Table I.
Week | Control (mg/dl) | GLB (mg/dl) | DM (mg/dl) | DM+GLB (mg/dl) | DM+GL (mg/dl) |
---|---|---|---|---|---|
1 | 70.50±4.92 | 67.00±5.15 | 360.50±32.33a | 314.83±30.71a | 297.67±20.69b |
2 | 72.00±5.49 | 88.50±7.75 | 290.50±34.44a | 311.67±49.73a | 241.00±36.43c |
3 | 79.17±3.25 | 100.50±5.68 | 351.17±43.25a | 305.33±52.59a | 176.50±38.65c |
4 | 73.33±3.57 | 86.33±2.67 | 243.67±30.75a | 170.67±41.11 | 187.50±45.61 |
5 | 72.00±3.98 | 75.67±3.55 | 301.50±55.41a | 137.00±40.87d | 192.50±54.94c |
6 | 73.58±3.55 | 82.83±1.51 | 351.00±34.82a | 69.50±13.69c | 149.00±47.48c |
7 | 73.00±4.25 | 83.00±4.37 | 457.00±20.99a | 158.33±37.64c | 165.83±49.04c |
8 | 74.67±3.31 | 81.17±3.73 | 353.83±35.16a | 174.50±30.99c | 160.67±52.46c |
Data are expressed as the mean ± standard error of the mean.
P<0.001
P<0.01 vs. control
P<0.001
P<0.01 vs. DM. GLB, glabridin; DM, diabetes mellitus; GL, glibenclamide.